Streetbeat News

Equity Actions

MELI

A significant bearish move has been observed in MercadoLibre's (NASDAQ:MELI) options trading. Analysis revealed 13 unusual trades, with 76% showing bearish tendencies. The significant investors are aiming for a price territory of $1200.0 to $1800.0 for MercadoLibre over the recent three months. The trading volume stands at 65,330, with MELI's price up 0.76%, positioned at $1385.19. Wedbush downgraded its action to Outperform with a price target of $1500.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 4:01 pm

CME

The article provides a detailed comparison of CME Group (NASDAQ:CME) with its competitors in the Capital Markets industry. The analysis includes key financial metrics, market position, and growth prospects. CME Group's P/E ratio is lower than the industry average, indicating potential for growth. Its P/B ratio suggests the stock may be undervalued. However, a high P/S ratio may indicate overvaluation in terms of sales performance. The company's ROE is below the industry average, suggesting potential inefficiency. However, CME Group has higher EBITDA and gross profit, indicating stronger profitability and robust cash flow generation. The company's revenue growth is notably higher than the industry average.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 4:00 pm

ABNB

A comprehensive industry comparison of Airbnb (NASDAQ:ABNB) and its primary competitors in the Hotels, Restaurants & Leisure industry reveals that Airbnb's P/E, P/B, and P/S ratios suggest potential undervaluation. However, its ROE is lower than the industry average, indicating potential inefficiency. Airbnb's EBITDA and gross profit are higher than the industry average, demonstrating strong profitability, but its revenue growth is lower than the industry average, suggesting a slowdown in sales expansion. Airbnb's debt-to-equity ratio is lower than its top 4 peers, indicating a healthier balance between debt and equity.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 4:00 pm

BMRN

IBB

Activist investor Elliott Investment Management has built a stake in BioMarin Pharmaceutical and has been in discussions with the company about its future. Elliott has spent over $1 billion on the stake in BioMarin, which focuses on rare genetic disorders and is valued at $14.6 billion. BioMarin is currently undergoing a change in chief executives and slow progress in the launch of its drug Roctavian. The company's shares are down 24% year-to-date, significantly underperforming the iShares Biotechnology ETF, which is down 8.6%.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:34 pm

AAPL

DDOG

DHI

NXPI

SPY

The stock market is looking for a trigger for the next move after a short squeeze in bonds led to a rally in stocks. Apple Inc has recovered after a weak earnings report, which is seen as an indication of investor sentiment. Positive earnings news from Datadog Inc, DR Horton Inc, and NXP Semiconductors NV is driving buying in related stocks. Money flows are positive in Amazon, Alphabet, Meta Platforms, and Microsoft, but negative in Apple, NVIDIA, and Tesla. Money flows are mixed in SPDR S&P 500 ETF Trust and Invesco QQQ Trust Series 1.

Portfolio Pulse from The Arora Report

November 07, 2023 | 3:23 pm

BABA

BIDU

NVDA

Nvidia Corp (NVDA) lost a significant artificial intelligence chip order from Baidu Inc (BIDU) to Huawei Technologies Co due to the U.S. embargo on AI technology chips for China. Despite this, Nvidia's A100 and H100 chips have dominated the global AI chip market. However, recent reports suggest that Nvidia may lose orders worth over $5 billion in 2024 from China's leading AI and cloud-computing companies, including Alibaba Group Holding Limited (BABA).

Portfolio Pulse from Anusuya Lahiri

November 07, 2023 | 3:15 pm

GVH

Globavend Holdings Limited (NASDAQ:GVH) is set to IPO on November 08 on the NASDAQ exchange under the ticker GVH. The company is offering shares at an expected price between $4.00 and $5.00 per share with an insider lock-up period of 180 days ending on May 06, 2024.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 3:00 pm

SHIM

Shimmick Corporation (NASDAQ:SHIM) is set to IPO on November 08 on the NASDAQ exchange. The company is offering shares at an expected price between $10.00 and $12.00 per share with an insider lock-up period of 180 days ending on May 06, 2024. Shimmick Corporation is a leading provider of water and other critical infrastructure solutions nationwide.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 3:00 pm

BABA

Alibaba Group (NYSE:BABA) is progressing with its artificial intelligence initiatives and IPO goals for its segments. The company's logistics arm, Cainiao, part of a consortium, has made a preliminary buyout offer to Chinese logistics company Best. The consortium plans to fund the deal primarily through Cainiao's equity capital and cash. Cainiao is preparing for its $1 billion Hong Kong IPO. Alibaba, which currently holds about 70% of Cainiao, will likely retain over 50% of the unit following the IPO. Alibaba's rival, Shein, is considering a U.S. IPO with a valuation of up to $490 billion.

Portfolio Pulse from Anusuya Lahiri

November 07, 2023 | 2:45 pm

HIMS

Hims & Hers reported better-than-expected Q3 sales results and raised its FY23 guidance above estimates. The company also announced a $50 million share repurchase program, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:31 pm